
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease
Leonardo Iaccarino, Gautam Tammewar, Nagehan Ayakta, et al.
NeuroImage Clinical (2017) Vol. 17, pp. 452-464
Open Access | Times Cited: 153
Leonardo Iaccarino, Gautam Tammewar, Nagehan Ayakta, et al.
NeuroImage Clinical (2017) Vol. 17, pp. 452-464
Open Access | Times Cited: 153
Showing 1-25 of 153 citing articles:
Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response
Sara Bachiller, Itzia Jiménez-Ferrer, Agnes Paulus, et al.
Frontiers in Cellular Neuroscience (2018) Vol. 12
Open Access | Times Cited: 617
Sara Bachiller, Itzia Jiménez-Ferrer, Agnes Paulus, et al.
Frontiers in Cellular Neuroscience (2018) Vol. 12
Open Access | Times Cited: 617
Tau PET imaging in neurodegenerative tauopathies—still a challenge
Antoine Leuzy, Konstantinos Chiotis, Laëtitia Lemoine, et al.
Molecular Psychiatry (2019) Vol. 24, Iss. 8, pp. 1112-1134
Open Access | Times Cited: 508
Antoine Leuzy, Konstantinos Chiotis, Laëtitia Lemoine, et al.
Molecular Psychiatry (2019) Vol. 24, Iss. 8, pp. 1112-1134
Open Access | Times Cited: 508
Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET
Renaud La Joie, Adrienne Visani, Suzanne L. Baker, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 524
Open Access | Times Cited: 475
Renaud La Joie, Adrienne Visani, Suzanne L. Baker, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 524
Open Access | Times Cited: 475
Imaging the evolution and pathophysiology of Alzheimer disease
William J. Jagust
Nature reviews. Neuroscience (2018) Vol. 19, Iss. 11, pp. 687-700
Open Access | Times Cited: 467
William J. Jagust
Nature reviews. Neuroscience (2018) Vol. 19, Iss. 11, pp. 687-700
Open Access | Times Cited: 467
Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain
Sarah L. DeVos, Bianca T. Corjuc, Derek H. Oakley, et al.
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 253
Sarah L. DeVos, Bianca T. Corjuc, Derek H. Oakley, et al.
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 253
Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease
Rik Ossenkoppele, Ruben Smith, Tomas Ohlsson, et al.
Neurology (2019) Vol. 92, Iss. 6
Open Access | Times Cited: 252
Rik Ossenkoppele, Ruben Smith, Tomas Ohlsson, et al.
Neurology (2019) Vol. 92, Iss. 6
Open Access | Times Cited: 252
A walk through tau therapeutic strategies
Santosh Jadhav, Jesús Ávila, Michael Schöll, et al.
Acta Neuropathologica Communications (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 248
Santosh Jadhav, Jesús Ávila, Michael Schöll, et al.
Acta Neuropathologica Communications (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 248
Biomarkers for tau pathology
Michael Schöll, Anne Maaß, Niklas Mattsson, et al.
Molecular and Cellular Neuroscience (2018) Vol. 97, pp. 18-33
Open Access | Times Cited: 192
Michael Schöll, Anne Maaß, Niklas Mattsson, et al.
Molecular and Cellular Neuroscience (2018) Vol. 97, pp. 18-33
Open Access | Times Cited: 192
Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer’s disease
Gary P. Morris, Ian A. Clark, Bryce Vissel
Acta Neuropathologica (2018) Vol. 136, Iss. 5, pp. 663-689
Open Access | Times Cited: 183
Gary P. Morris, Ian A. Clark, Bryce Vissel
Acta Neuropathologica (2018) Vol. 136, Iss. 5, pp. 663-689
Open Access | Times Cited: 183
Prevention of dementia in an ageing world: Evidence and biological rationale
Giulia Grande, Chengxuan Qiu, Laura Fratiglioni
Ageing Research Reviews (2020) Vol. 64, pp. 101045-101045
Open Access | Times Cited: 170
Giulia Grande, Chengxuan Qiu, Laura Fratiglioni
Ageing Research Reviews (2020) Vol. 64, pp. 101045-101045
Open Access | Times Cited: 170
Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases
Urmi Sengupta, Rakez Kayed
Progress in Neurobiology (2022) Vol. 214, pp. 102270-102270
Open Access | Times Cited: 161
Urmi Sengupta, Rakez Kayed
Progress in Neurobiology (2022) Vol. 214, pp. 102270-102270
Open Access | Times Cited: 161
Lifespan Changes of the Human Brain In Alzheimer’s Disease
Pierrick Coupé, José V. Manjón, Enrique Lanuza, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 160
Pierrick Coupé, José V. Manjón, Enrique Lanuza, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 160
Data-driven modelling of neurodegenerative disease progression: thinking outside the black box
Alexandra L. Young, Neil P. Oxtoby, Sara Garbarino, et al.
Nature reviews. Neuroscience (2024) Vol. 25, Iss. 2, pp. 111-130
Closed Access | Times Cited: 27
Alexandra L. Young, Neil P. Oxtoby, Sara Garbarino, et al.
Nature reviews. Neuroscience (2024) Vol. 25, Iss. 2, pp. 111-130
Closed Access | Times Cited: 27
Plasma tau/amyloid-β1–42 ratio predicts brain tau deposition and neurodegeneration in Alzheimer’s disease
Jong‐Chan Park, Sun-Ho Han, Dahyun Yi, et al.
Brain (2018) Vol. 142, Iss. 3, pp. 771-786
Open Access | Times Cited: 140
Jong‐Chan Park, Sun-Ho Han, Dahyun Yi, et al.
Brain (2018) Vol. 142, Iss. 3, pp. 771-786
Open Access | Times Cited: 140
Distinct tau PET patterns in atrophy‐defined subtypes of Alzheimer's disease
Rik Ossenkoppele, Chul Hyoung Lyoo, Carole H. Sudre, et al.
Alzheimer s & Dementia (2019) Vol. 16, Iss. 2, pp. 335-344
Open Access | Times Cited: 97
Rik Ossenkoppele, Chul Hyoung Lyoo, Carole H. Sudre, et al.
Alzheimer s & Dementia (2019) Vol. 16, Iss. 2, pp. 335-344
Open Access | Times Cited: 97
Recent update on the heterogeneity of the Alzheimer’s disease spectrum
K. A. Jellinger
Journal of Neural Transmission (2021) Vol. 129, Iss. 1, pp. 1-24
Closed Access | Times Cited: 85
K. A. Jellinger
Journal of Neural Transmission (2021) Vol. 129, Iss. 1, pp. 1-24
Closed Access | Times Cited: 85
Alzheimer’s disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery?
Kevin Mullane, Michael Williams
Biochemical Pharmacology (2020) Vol. 177, pp. 113945-113945
Closed Access | Times Cited: 84
Kevin Mullane, Michael Williams
Biochemical Pharmacology (2020) Vol. 177, pp. 113945-113945
Closed Access | Times Cited: 84
PET Neuroimaging of Alzheimer's Disease: Radiotracers and Their Utility in Clinical Research
Weiqi Bao, Fang Xie, Chuantao Zuo, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 70
Weiqi Bao, Fang Xie, Chuantao Zuo, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 70
Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer’s disease
Amelia Strom, Leonardo Iaccarino, Lauren Edwards, et al.
Brain (2021) Vol. 145, Iss. 2, pp. 713-728
Open Access | Times Cited: 68
Amelia Strom, Leonardo Iaccarino, Lauren Edwards, et al.
Brain (2021) Vol. 145, Iss. 2, pp. 713-728
Open Access | Times Cited: 68
Single-cell RNA sequencing reveals B cell–related molecular biomarkers for Alzheimer’s disease
Liu‐Lin Xiong, Lu‐Lu Xue, Ruo‐Lan Du, et al.
Experimental & Molecular Medicine (2021) Vol. 53, Iss. 12, pp. 1888-1901
Open Access | Times Cited: 66
Liu‐Lin Xiong, Lu‐Lu Xue, Ruo‐Lan Du, et al.
Experimental & Molecular Medicine (2021) Vol. 53, Iss. 12, pp. 1888-1901
Open Access | Times Cited: 66
Current Understanding of the Physiopathology, Diagnosis and Therapeutic Approach to Alzheimer’s Disease
Victoria García‐Morales, Anabel González‐Acedo, Lucia Melguizo‐Rodríguez, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1910-1910
Open Access | Times Cited: 57
Victoria García‐Morales, Anabel González‐Acedo, Lucia Melguizo‐Rodríguez, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1910-1910
Open Access | Times Cited: 57
Amyloid-β and tau pathologies relate to distinctive brain dysconnectomics in preclinical autosomal-dominant Alzheimer’s disease
Edmarie Guzmán‐Vélez, Ibai Díez, Dorothée Schoemaker, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 15
Open Access | Times Cited: 57
Edmarie Guzmán‐Vélez, Ibai Díez, Dorothée Schoemaker, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 15
Open Access | Times Cited: 57
Genetically modified non-human primate models for research on neurodegenerative diseases
Ming-Tian Pan, Han Zhang, Xiao‐Jiang Li, et al.
动物学研究 (2024) Vol. 45, Iss. 2, pp. 263-274
Open Access | Times Cited: 10
Ming-Tian Pan, Han Zhang, Xiao‐Jiang Li, et al.
动物学研究 (2024) Vol. 45, Iss. 2, pp. 263-274
Open Access | Times Cited: 10
Could Alzheimer’s Disease Originate in the Periphery and If So How So?
Gerwyn Morris, Michael Berk, Michaël Maes, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 1, pp. 406-434
Open Access | Times Cited: 80
Gerwyn Morris, Michael Berk, Michaël Maes, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 1, pp. 406-434
Open Access | Times Cited: 80
Molecular imaging in dementia: Past, present, and future
Robert Laforce, Jean‐Paul Soucy, Leila Sellami, et al.
Alzheimer s & Dementia (2018) Vol. 14, Iss. 11, pp. 1522-1552
Closed Access | Times Cited: 80
Robert Laforce, Jean‐Paul Soucy, Leila Sellami, et al.
Alzheimer s & Dementia (2018) Vol. 14, Iss. 11, pp. 1522-1552
Closed Access | Times Cited: 80